RPC Pharma Ltd 13D and 13G filings for Akari Therapeutics, Plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-06-20 07:30 am Purchase | 2024-05-31 | 13D | AKARI THERAPEUTICS PLC SPONSOR AKTX | RPC Pharma Ltd | 112,682,870 19.200% | 25,558,922 (+29.34%) | Filing |
| 2024-01-04 12:34 pm Purchase | 2024-01-01 | 13D | AKARI THERAPEUTICS PLC SPONSOR AKTX | RPC Pharma Ltd | 87,123,948 26.400% | 23,696,700 (+37.36%) | Filing |